对含马兜铃酸类中药被取消药用标准的讨论  

On the Cancellation of the Medicinal Standards of Aristolochic Acid-containing Chinese Medicines

作　　者：岑显娜[1] 

机构地区：[1]广西柳州医学高等专科学校第一附属医院,柳州市545002

出　　处：《中国药房》2007年第30期2321-2322,共2页China Pharmacy

摘　　要：目的:探讨马兜铃酸类中药被取消药用标准的有关问题。方法:分析含马兜铃酸类中药引起马兜铃酸肾毒性的原因。结果与结论:对含马兜铃酸药物的肾毒性应予以足够的重视,但应客观、理性对待其肾毒性。OBJECTIVE： To discuss the issue related to the cancellation of the medicinal standards for Aristolochic acid - containing Chinese medicines containing Aristolochic acid. METHODS： We analyzed the causes accountable for the renal toxicity of Aristolochic acid-containing Chinese medicines. RESULTS ＆ CONCLUSION： We should attach great importance to the renal toxicity induced by Aristolochic acid-containing Chinese medicines; however, the renal toxicity should be treated objectively and rationally.

关 键 词：马兜铃酸 肾毒性 药用标准 

分 类 号：R288[医药卫生—中药学] R99[医药卫生—中医学]